Common Stock

9 Months Ended

Oct. 31, 2021

Equity [Abstract]

Common Stock

Common Stock

On February 26, 2021, the Merger was consummated and the Company issued 60,746,989 shares for an aggregate purchase price of $200.5 million, net of issuance costs of $29.4 million. Immediately following the Merger, there were 277,768,357 shares of Common Stock outstanding with a par value of $0.0001. The holder of each share of Common Stock is entitled to one vote.

The Company has retroactively adjusted the shares issued and outstanding prior to February 26, 2021, to give effect to the Exchange Ratio established in the Merger Agreement to determine the number of shares of Common Stock into which they were converted. Immediately prior to the Merger, 484,951,532 shares were authorized to issue at $0.0001 par value, with 299,771,284 shares designated as Common Stock and 185,180,248 shares of redeemable convertible preferred stock.

Common Stock Reserved for Future Issuance

Shares of Common Stock reserved for future issuance, on an as-if converted basis, were as follows:

	October 31, 2021
Stock options issued and outstanding	24,855,043
Restricted stock units outstanding	3,906,058
Common stock warrants outstanding	37,756,829
Shares available for grant under 2021 Equity Incentive Plan	36,436,447
Shares available for grant under 2021 ESPP	8,177,683
Total shares of Common Stock reserved	111,132,060

On February 26, 2021, upon the closing of the Merger (Note 3), all of the outstanding redeemable convertible preferred stock was converted to Common Stock pursuant to the conversion rate effective immediately prior to the Merger, and the remaining amount was reclassified to additional paid-in capital.